Evidence map›Paper›PMID 35422871›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Network Pharmacology-Based Strategy for Exploring the Pharmacological Mechanism of Honeysuckle (

Yi Lu, Wen A Huang, Zhi B He, Shan Li, Jun Liu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yi LuMedical College, Jiujiang University, Jiujiang 332005, China.ORCID https://orcid.org/0000-0002-4241-4418
Wen A HuangMedical College, Jiujiang University, Jiujiang 332005, China.ORCID https://orcid.org/0000-0001-6934-9356
Zhi B HeSchool of Foreign Languages, Jiujiang University, Jiujiang 332005, China.ORCID https://orcid.org/0000-0003-3990-0324
Shan LiMedical College, Jiujiang University, Jiujiang 332005, China.ORCID https://orcid.org/0000-0002-0824-251X
Jun LiuMedical College, Jiujiang University, Jiujiang 332005, China.ORCID https://orcid.org/0000-0002-9885-5941
Jiujiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Newcastle disease causes huge economic losses in the global poultry industry. An efficient treatment is needed to deal with the variable immunogenicity of the Newcastle disease virus (NDV). This study utilized network pharmacology to study the potential therapeutic targets of Honeysuckle ( Methods: Venny online analysis was used to analyze the potential overlapping targets of Honeysuckle and Newcastle disease. Hub genes were obtained using the STRING database and Cytoscape 3.8.2 software. Gene Ontology (GO) functions and Kyoto Encyclopedia of Genes and Genomics (KEGG) pathway enrichment analysis using the DAVID online tool were performed on these targets. Results: Twenty-five overlapping targets were identified. The PPI network construction results included 23 nodes of 25 genes and 95 edges. It was found that the IL-6 node had the largest degree. STAT1 and IRF1, CASP9, and CASP3 had the same as well as strongest interaction strengths. GO functions, such as "cytokine activity," had a regulatory effect on NDV. The "Toll-like receptor signaling Pathway" "Nod-like receptor signaling pathway," "RIG-I-like receptor signaling pathway," and "Apoptosis," which were obtained using KEGG analysis, also indicated that these pathways can act on NDV to enhance immune function. Conclusions: In this study, the potential targets and mechanisms of action of Honeysuckle against Newcastle disease were explored through network pharmacology, which provided a theoretical basis for the treatment of Newcastle disease and provided new ideas for the development of traditional Chinese medicine for the poultry industry.

Identifiers

PMID35422871
PMCPMC9005276
OpenAlexW4225655910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.